Prevalence and Determinants of Pre-Cancerous Cervical Lesion and Human Papillomavirus Among HIV-Infected and HIV-Uninfected Women in North-West Ethiopia: A Comparative Retrospective Cross-Sectional Study

References

• Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–e203. doi:10.1016/S2214-109X(19)30482-6
   PubMed Web of Science ®Google Scholar
• Ferreira MP, Coghill AE, Chaves CB, et al. Outcomes of cervical cancer among HIV-infected and HIV-uninfected women treated at the Brazilian National Institute of Cancer. AIDS. 2017;31(4):523–531. doi:10.1097/QAD.0000000000001367
   Web of Science ®Google Scholar
• Mboumba Bouassa R-S, Prazuck T, Lethu T, Jenabian M-A, Meye J-F, Bélec L. Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease. Expert Rev Anti Infect Ther. 2017;15(6):613–627. doi:10.1080/14787210.2017.1322902
   PubMed Web of Science ®Google Scholar
• Jedy-Agba E, Joko WY, Liu B, et al. Trends in cervical cancer incidence in sub-Saharan Africa. British journal of cancer. 2020;123(1):148–154. doi:10.1038/s41416-020-0831-9
   PubMed Web of Science ®Google Scholar
• Huchko MJ, Sneden J, Leslie HH, et al. A comparison of two visual inspection methods for cervical cancer screening among HIV-infected women in Kenya. Bull World Health Organ. 2014;92(3):195–203. doi:10.2471/BLT.13.122051
   Web of Science ®Google Scholar
• Krings A, Dückelmann AM, Moser L, et al. Performance of OncoE6 cervical test with collection methods enabling self-sampling. BMC Womens Health. 2018;18(1):1–7. doi:10.1186/s12905-018-0559-3
   Web of Science ®Google Scholar
• Begoihn M, Mathewos A, Aynalem A, et al. Cervical cancer in Ethiopia – predictors of advanced stage and prolonged time to diagnosis. Infect Agent Cancer. 2019;14(1):36. doi:10.1186/s13027-019-0255-4
   Web of Science ®Google Scholar
• Gemeda EY, Kare BB, Negera DG, et al. Prevalence and predictor of cervical cancer screening service uptake among women aged 25 years and above in Sidama Zone, Southern Ethiopia, Using Health Belief Model. Cancer Control. 2020;27(1):1073274820954460. doi:10.1177/1073274820954460
   Web of Science ®Google Scholar
• Girum T, Wasie A, Lentiro K, et al. Gender disparity in epidemiological trend of HIV/AIDS infection and treatment in Ethiopia. Arch Public Health. 2018;76(1):51. doi:10.1186/s13690-018-0299-8
   PubMed Web of Science ®Google Scholar
• Leece P, Kendall C, Touchie C, Pottie K, Angel JB, Jaffey J. Cervical cancer screening among HIV-positive women: retrospective cohort study from a tertiary care HIV clinic. Can Fam Physician. 2010;56(12):e425–e31.
   Web of Science ®Google Scholar
• Dessalegn Mekonnen B. Cervical cancer screening uptake and associated factors among HIV-positive women in Ethiopia: a systematic review and meta-analysis. Adv Prev Med. 2020;2020:7071925. doi:10.1155/2020/7071925
   Google Scholar
• Trejo MJ, Lishimpi K, Kalima M, et al. Effects of HIV status on non-metastatic cervical cancer progression among patients in Lusaka, Zambia. Int J Gynecol Cancer. 2020;30(5):613–618. doi:10.1136/ijgc-2019-000987
   Web of Science ®Google Scholar
• Jolly PE, Mthethwa-Hleta S, Padilla LA, et al. Screening, prevalence, and risk factors for cervical lesions among HIV positive and HIV negative women in Swaziland. BMC Public Health. 2017;17(1):1–8. doi:10.1186/s12889-017-4120-3
   Web of Science ®Google Scholar
• Chambuso RS, Shadrack S, Lidenge SJ, Mwakibete N, Medeiros RM. Influence of HIV/AIDS on cervical cancer: a retrospective study from Tanzania. Journal of global oncology. 2017;3(1):72–8.
   Google Scholar
• Belayneh T, Mitiku H, Weldegebreal F. Precancerous cervical lesion and associated factors among HIV-infected women on ART in Amhara Regional State, Ethiopia: a hospital-based cross-sectional study. Int J Health Sci. 2019;13(3):4–9.
   PubMedGoogle Scholar
• Misgina KH, Belay HS, Abraha TH. Prevalence of precancerous cervical lesion and associated factors among women in North Ethiopia. J Public Health Epidemiol. 2017;9(3):46–50. doi:10.5897/JPHE2016.0891
   Google Scholar
• Mulissa Z, Alemseged F, Assefa H. Prevalence and factors associated with precancerous cervical lesions among clients screened at family guidance association of Ethiopia, south west area office, jimma model clinic, jimma, 2013. 2014.
   Google Scholar
• Makuza JD, Nsanzimana S, Muhimpundu MA, Pace LE, Ntaganira J, Riedel DJ. Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda. Pan Afr Med J. 2015;22(1). doi:10.11604/pamj.2015.22.26.7116
   PubMedGoogle Scholar
• Bakari F, Abdul MA, Ahmed SA. The prevalence and course of preinvasive cervical lesions during pregnancy in a Northern Nigerian Teaching Hospital. Ann Afr Med. 2017;16(2):74. doi:10.4103/aam.aam_35_16
   Web of Science ®Google Scholar
• Nkfusai NC, Mubah TM, Yankam BM, Tambe TA, Cumber SN. Prevalence of precancerous cervical lesions in women attending Mezam Polyclinic Bamenda, Cameroon. Pan Afr Med J. 2019;32.
   Web of Science ®Google Scholar
• Gedefaw A, Astatkie A, Tessema GA, Atashili J. The prevalence of precancerous cervical cancer lesion among HIV-infected women in southern Ethiopia: a cross-sectional study. PLoS One. 2013;8(12):e84519. doi:10.1371/journal.pone.0084519
   Web of Science ®Google Scholar
• Mabeya H, Khozaim K, Liu T, et al. Comparison of conventional cervical cytology versus visual inspection with acetic acid (VIA) among HIV-infected women in western Kenya. J Low Genit Tract Dis. 2012;16(2):92. doi:10.1097/LGT.0b013e3182320f0c
   PubMed Web of Science ®Google Scholar
• Teame H, Addissie A, Ayele W, et al. Factors associated with cervical precancerous lesions among women screened for cervical cancer in Addis Ababa, Ethiopia: a case control study. PLoS One. 2018;13(1):e0191506. doi:10.1371/journal.pone.0191506
   Web of Science ®Google Scholar
• Teka T, Kote M, Kejela G, Getachew T. Magnitude and factors associated with precervical cancer among screened women in Southern Ethiopia. Adv Public Health. 2019;2019:1–8. doi:10.1155/2019/5049752
   Google Scholar
• Ali KE, Mohammed IA, Difabachew MN, Demeke DS, Haile T, Ten Hove R-J, et al. Burden and genotype distribution of high-risk Human Papillomavirus infection and cervical cytology abnormalities at selected obstetrics and gynecology clinics of Addis Ababa, Ethiopia. BMC cancer. Adv Public Health. 2019;19(1):1–9.
   Google Scholar
• Teka B, Gizaw M, Ruddies F, Addissie A, Chanyalew Z, Skof AS, et al. Population–based human papillomavirus infection and genotype distribution among women in rural areas of South Central Ethiopia. International Journal of Cancer. 2021;148(3):723–30.
   Google Scholar
• Leyh-Bannurah S-R, Prugger C, de Koning MN, Goette H, Lellé RJ. Cervical human papillomavirus prevalence and genotype distribution among hybrid capture 2 positive women 15 to 64 years of age in the Gurage zone, rural Ethiopia. Infectious agents and cancer. 2014;9(1):1–9.
   Google Scholar